ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 171 filers reported holding ASCENDIS PHARMA A/S in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $49,289,380 | -19.8% | 526,371 | -23.6% | 0.11% | -16.4% |
| Q2 2023 | $61,493,250 | +14.7% | 689,000 | +37.8% | 0.13% | +11.7% |
| Q1 2023 | $53,610,000 | -31.4% | 500,000 | -21.9% | 0.12% | -35.8% |
| Q4 2022 | $78,163,200 | +229.1% | 640,000 | +178.3% | 0.19% | +216.9% |
| Q3 2022 | $23,750,000 | +54.8% | 230,000 | +39.4% | 0.06% | +68.6% |
| Q2 2022 | $15,338,000 | -24.0% | 165,000 | -4.1% | 0.04% | -7.9% |
| Q1 2022 | $20,186,000 | +200.1% | 172,000 | +244.0% | 0.04% | +216.7% |
| Q4 2021 | $6,727,000 | +51.6% | 50,000 | +66.7% | 0.01% | +9.1% |
| Q2 2020 | $4,437,000 | -1.5% | 30,000 | -25.0% | 0.01% | -15.4% |
| Q1 2020 | $4,504,000 | -19.1% | 40,000 | 0.0% | 0.01% | -7.1% |
| Q4 2019 | $5,565,000 | -71.1% | 40,000 | -80.0% | 0.01% | -70.2% |
| Q3 2019 | $19,264,000 | -33.1% | 200,000 | -20.0% | 0.05% | -34.7% |
| Q2 2019 | $28,788,000 | +8.7% | 250,000 | +11.1% | 0.07% | +9.1% |
| Q1 2019 | $26,483,000 | +30.1% | 225,000 | -30.8% | 0.07% | +17.9% |
| Q4 2018 | $20,361,000 | +14.9% | 325,000 | +30.0% | 0.06% | +40.0% |
| Q3 2018 | $17,715,000 | +18.4% | 250,000 | +11.1% | 0.04% | +17.6% |
| Q2 2018 | $14,967,000 | -60.2% | 225,000 | -60.9% | 0.03% | -61.4% |
| Q1 2018 | $37,605,000 | +4841.5% | 575,000 | +2926.3% | 0.09% | +4300.0% |
| Q4 2017 | $761,000 | – | 19,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |